Nicolas Guibert, MD, PhD, on Non–Small Cell Lung Cancer: Clinical Implications of Using a New Algorithm to Predict Response to Immunotherapy

Posted: Tuesday, March 12, 2019

Nicolas Guibert, MD, PhD, of Toulouse University Hospital, talks about the possible future role of a new algorithm used to predict outcomes with immunotherapy in advanced non–small cell lung cancer.